| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA320: Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis |
|
Medicine details |
|
| Medicine name | dimethyl fumarate (Tecfidera®) |
| Formulation | 120 mg, 240 mg capsule |
| Reference number | 491 |
| Indication | Treatment of adult patients with relapsing-remitting multiple sclerosis |
| Company | Biogen Idec Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 26/06/2013 |
| NICE guidance | TA320: Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis |